SARRAV Trademark

Trademark Overview

On Monday, April 18, 2022, a trademark application was filed for SARRAV with the United States Patent and Trademark Office. The USPTO has given the SARRAV trademark a serial number of 97368224. The federal status of this trademark filing is ABANDONED - FAILURE TO RESPOND OR LATE RESPONSE as of Monday, June 19, 2023. This trademark is owned by Gowey Research Group. The SARRAV trademark is filed in the Pharmaceutical Products category with the following description:

Antivirals
sarrav

General Information

Serial Number97368224
Word MarkSARRAV
Filing DateMonday, April 18, 2022
Status602 - ABANDONED - FAILURE TO RESPOND OR LATE RESPONSE
Status DateMonday, June 19, 2023
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateNOT AVAILABLE

Trademark Statements

Goods and ServicesAntivirals

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateMonday, April 25, 2022
Primary Code005
First Use Anywhere DateFriday, January 1, 2021
First Use In Commerce DateFriday, January 1, 2021

Trademark Owner History

Party NameGowey Research Group
Party Type10 - Original Applicant
Legal Entity Type16 - Limited Liability Company
AddressFlagstaff, AZ 86004

Trademark Events

Event DateEvent Description
Tuesday, June 20, 2023ABANDONMENT NOTICE E-MAILED - FAILURE TO RESPOND
Monday, June 19, 2023ABANDONMENT NOTICE MAILED - FAILURE TO RESPOND
Monday, June 19, 2023ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE
Wednesday, March 1, 2023NOTIFICATION OF SUBSEQUENT FINAL EMAILED
Wednesday, March 1, 2023SUBSEQUENT FINAL EMAILED
Wednesday, March 1, 2023SUBSEQUENT FINAL REFUSAL WRITTEN
Tuesday, February 28, 2023TEAS/EMAIL CORRESPONDENCE ENTERED
Monday, February 27, 2023CORRESPONDENCE RECEIVED IN LAW OFFICE
Monday, February 27, 2023TEAS RESPONSE TO OFFICE ACTION RECEIVED
Tuesday, February 21, 2023NOTIFICATION OF NON-FINAL ACTION E-MAILED
Tuesday, February 21, 2023NON-FINAL ACTION E-MAILED
Tuesday, February 21, 2023NON-FINAL ACTION WRITTEN
Monday, February 20, 2023TEAS/EMAIL CORRESPONDENCE ENTERED
Monday, February 20, 2023CORRESPONDENCE RECEIVED IN LAW OFFICE
Monday, February 20, 2023TEAS RESPONSE TO OFFICE ACTION RECEIVED
Thursday, February 16, 2023NOTIFICATION OF NON-FINAL ACTION E-MAILED
Thursday, February 16, 2023NON-FINAL ACTION E-MAILED
Thursday, February 16, 2023NON-FINAL ACTION WRITTEN
Wednesday, February 15, 2023TEAS/EMAIL CORRESPONDENCE ENTERED
Wednesday, February 15, 2023CORRESPONDENCE RECEIVED IN LAW OFFICE
Wednesday, February 15, 2023TEAS REQUEST FOR RECONSIDERATION RECEIVED
Monday, February 13, 2023NOTIFICATION OF FINAL REFUSAL EMAILED
Monday, February 13, 2023FINAL REFUSAL E-MAILED
Monday, February 13, 2023FINAL REFUSAL WRITTEN
Thursday, February 9, 2023TEAS/EMAIL CORRESPONDENCE ENTERED
Wednesday, February 8, 2023CORRESPONDENCE RECEIVED IN LAW OFFICE
Wednesday, February 8, 2023TEAS RESPONSE TO OFFICE ACTION RECEIVED
Friday, February 3, 2023NOTIFICATION OF NON-FINAL ACTION E-MAILED
Friday, February 3, 2023NON-FINAL ACTION E-MAILED
Friday, February 3, 2023NON-FINAL ACTION WRITTEN
Friday, February 3, 2023ASSIGNED TO EXAMINER
Monday, April 25, 2022NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Thursday, April 21, 2022NEW APPLICATION ENTERED

Related Keywords

sarrav antivirals